Ming-Tain Lai

All Stories

1. 
   Doravirine Suppresses Common Nonnucleoside Reverse Transcriptase Inhibitor-Associated Mutants at Clinically Relevant Concentrations

   Article • Antimicrobial Agents and Chemotherapy, February 2016, ASM Journals

   Ming-Tain Lai

2. 
   In VitroResistance Selection with Doravirine (MK-1439), a Novel Nonnucleoside Reverse Transcriptase Inhibitor with Distinct Mutation Development Pathways

   Article • Antimicrobial Agents and Chemotherapy, November 2014, ASM Journals

   Ming-Tain Lai

3. 
   In VitroCharacterization of MK-1439, a Novel HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor

   Article • Antimicrobial Agents and Chemotherapy, December 2013, ASM Journals

   Ming-Tain Lai